Strong evidence suggests that food allergies are caused by a lack of exposure to food allergens—not by exposure to toxins ...
The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's drug for patients with a form of lung ...
Pharmaceutical Technology on MSN
Arrowhead nets first commercial win as siRNA drug garners FDA approval
Redemplo’s approval in familial chylomicronemia syndrome places the drug in competition with Ionis’ Tryngolza.
J&J (JNJ) stock and Halozyme Therapeutics (HALO) stock are in focus as their multiple myeloma therapy Darzalex Faspro is granted traditional FDA nod. Read more here.
Zacks Small Cap Research on MSN
ARWR: REDEMPLO® Approved by FDA for the Treatment of FCS…
ARWR READ THE FULL ARWR RESEARCH REPORT Business Update REDEMPLO® Approved by FDA On November 18, 2025, Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) announced that the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback